z-logo
open-access-imgOpen Access
Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant
Author(s) -
George Chen,
Megan M. Herr,
Jan Nowak,
Christine M. Ho,
Nikolaos G. Almyroudis,
Kristopher Attwood,
John Bonnewell,
Marissa Walsh,
Brahm H. Segal,
Maureen Ross,
Philip L. McCarthy,
Theresa Hahn
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2022.281719
Subject(s) - cytomegalovirus , virology , medicine , cd19 , car t cell therapy , immunology , herpesviridae , viral disease , virus , t cell , antibody , chimeric antigen receptor , immune system

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here